Neoadjuvant immune checkpoint inhibitor therapy in resectable non-small cell lung cancer

被引：11

作者：

Conroy, Michael R. ^{[1
]}

Dennehy, Colum ^{[1
]}

Forde, Patrick M. ^{[1
,2
]}

机构：

[1] Johns Hopkins Univ, Bloomberg Kimmel Inst Canc Immunotherapy, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[2] 201 N Broadway,Viragh Bldg 8129, Baltimore, MD 21231 USA

来源：

LUNG CANCER | 2023年 / 183卷

关键词：

Neoadjuvant; Immunotherapy; NSCLC; Biomarker; Chemotherapy; PHASE-II; PREOPERATIVE CHEMOTHERAPY; PATHOLOGICAL RESPONSE; OPEN-LABEL; INDUCTION CHEMORADIATION; ADJUVANT THERAPY; SINGLE-ARM; IB; ATEZOLIZUMAB; MULTICENTER;

D O I：

10.1016/j.lungcan.2023.107314

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Only a minority of lung cancers are resectable at diagnosis, and many of these will eventually relapse. Adjuvant chemotherapy in this setting has a modest survival advantage, and there is significant need for new approaches to improve cure rates. Checkpoint inhibitor immunotherapy has transformed the prognosis for advanced lung cancer, and is increasingly being used in the neoadjuvant setting alone, or in combination with cytotoxic chemotherapy. While this has demonstrated convincing improvements in event-free survival and pathologic response, questions remain over optimal duration of therapy, predictive and prognostic biomarkers, response assessment and combination with other modalities. In addition, these results must be considered in the context of recent positive studies of adjuvant immunotherapy. Here, we summarise preclinical context and clinical trials in this space, discuss areas of controversy and pitfalls, and consider future challenges.

引用

页数：12

共 108 条

[1] ADAURA: Mature Enough for Publication, Not for Prime Time [J].

Addeo, Alfredo ;

Banna, Giuseppe Luigi ;

Friedlaender, Alex .

ONCOLOGIST, 2021, 26 (04) :266-268

[2]

Akinboro O, 2022, J CLIN ONCOL, V40

[3]

ALBERTI W, 1995, BRIT MED J, V311, P899

[4] Signatures of mutational processes in human cancer [J].

Alexandrov, Ludmil B. ;

Nik-Zainal, Serena ;

Wedge, David C. ;

Aparicio, Samuel A. J. R. ;

Behjati, Sam ;

Biankin, Andrew V. ;

Bignell, Graham R. ;

Bolli, Niccolo ;

Borg, Ake ;

Borresen-Dale, Anne-Lise ;

Boyault, Sandrine ;

Burkhardt, Birgit ;

Butler, Adam P. ;

Caldas, Carlos ;

Davies, Helen R. ;

Desmedt, Christine ;

Eils, Roland ;

Eyfjord, Jorunn Erla ;

Foekens, John A. ;

Greaves, Mel ;

Hosoda, Fumie ;

Hutter, Barbara ;

Ilicic, Tomislav ;

Imbeaud, Sandrine ;

Imielinsk, Marcin ;

Jaeger, Natalie ;

Jones, David T. W. ;

Jones, David ;

Knappskog, Stian ;

Kool, Marcel ;

Lakhani, Sunil R. ;

Lopez-Otin, Carlos ;

Martin, Sancha ;

Munshi, Nikhil C. ;

Nakamura, Hiromi ;

Northcott, Paul A. ;

Pajic, Marina ;

Papaemmanuil, Elli ;

Paradiso, Angelo ;

Pearson, John V. ;

Puente, Xose S. ;

Raine, Keiran ;

Ramakrishna, Manasa ;

Richardson, Andrea L. ;

Richter, Julia ;

Rosenstiel, Philip ;

Schlesner, Matthias ;

Schumacher, Ton N. ;

Span, Paul N. ;

Teague, Jon W. .

NATURE, 2013, 500 (7463) :415-+

[5] Neoadjuvant relatlimab and nivolumab in resectable melanoma [J].

Amaria, Rodabe N. ;

Postow, Michael ;

Burton, Elizabeth M. ;

Tezlaff, Michael T. ;

Ross, Merrick, I ;

Torres-Cabala, Carlos ;

Glitza, Isabella C. ;

Duan, Fei ;

Milton, Denai R. ;

Busam, Klaus ;

Simpson, Lauren ;

McQuade, Jennifer L. ;

Wong, Michael K. ;

Gershenwald, Jeffrey E. ;

Lee, Jeffrey E. ;

Goepfert, Ryan P. ;

Keung, Emily Z. ;

Fisher, Sarah B. ;

Betof-Warner, Allison ;

Shoushtari, Alexander N. ;

Callahan, Margaret ;

Coit, Daniel ;

Bartlett, Edmund K. ;

Bello, Danielle ;

Momtaz, Parisa ;

Nicholas, Courtney ;

Gu, Aidi ;

Zhang, Xuejun ;

Korivi, Brinda Rao ;

Patnana, Madhavi ;

Patel, Sapna P. ;

Diab, Adi ;

Lucci, Anthony ;

Prieto, Victor G. ;

Davies, Michael A. ;

Allison, James P. ;

Sharma, Padmanee ;

Wargo, Jennifer A. ;

Ariyan, Charlotte ;

Tawbi, Hussein A. .

NATURE, 2022, 611 (7934) :155-+

[6] Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer [J].

Anagnostou, Valsamo ;

Forde, Patrick M. ;

White, James R. ;

Niknafs, Noushin ;

Hruban, Carolyn ;

Naidoo, Jarushka ;

Marrone, Kristen ;

Sivakumar, I. K. Ashok ;

Bruhm, Daniel C. ;

Rosner, Samuel ;

Phallen, Jillian ;

Leal, Alessandro ;

Adleff, Vilmos ;

Smith, Kellie N. ;

Cottrell, Tricia R. ;

Rhymee, Lamia ;

Palsgrove, Doreen N. ;

Hann, Christine L. ;

Levy, Benjamin ;

Feliciano, Josephine ;

Georgiades, Christos ;

Verde, Franco ;

Illei, Peter ;

Li, Qing Kay ;

Gabrielson, Edward ;

Brock, Malcolm V. ;

Isbell, James M. ;

Sauter, Jennifer L. ;

Taube, Janis ;

Scharpf, Robert B. ;

Karchin, Rachel ;

Pardoll, Drew M. ;

Chaft, Jamie E. ;

Hellmann, Matthew D. ;

Brahmer, Julie R. ;

Velculescu, Victor E. .

CANCER RESEARCH, 2019, 79 (06) :1214-1225

[7] Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer [J].

Anagnostou, Valsamo ;

Smith, Kellie N. ;

Forde, Patrick M. ;

Niknafs, Noushin ;

Bhattacharya, Rohit ;

White, James ;

Zhang, Theresa ;

Adleff, Vilmos ;

Phallen, Jillian ;

Wali, Neha ;

Hruban, Carolyn ;

Guthrie, Violeta B. ;

Rodgers, Kristen ;

Naidoo, Jarushka ;

Kang, Hyunseok ;

Sharfman, William ;

Georgiades, Christos ;

Verde, Franco ;

Illei, Peter ;

Li, Qing Kay ;

Gabrielson, Edward ;

Brock, Malcolm V. ;

Zahnow, Cynthia A. ;

Baylin, Stephen B. ;

Scharpf, Robert B. ;

Brahmer, Julie R. ;

Karchin, Rachel ;

Pardoll, Drew M. ;

Velculescu, Victor E. .

CANCER DISCOVERY, 2017, 7 (03) :264-276

[8]

astrazeneca, 2023, Tagrisso demonstrated strong overall survival benefit in the ADAURA Phase III trial for adjuvant treatment of patients with early-stage EGFR-mutated lung cancer 2023

[9] Neoadjuvant atezolizumab (A) for resectable non-small cell lung cancer (NSCLC): Results from the phase II PRINCEPS trial [J].

Besse, B. ;

Adam, J. ;

Cozic, N. ;

Chaput-Gras, N. ;

Planchard, D. ;

Mezquita, L. ;

Remon Masip, J. ;

Lavaud, P. ;

Naltet, C. ;

Gazzah, A. ;

de Montpreville, V. Thomas ;

Ghigna, M. -R. ;

Mussot, S. ;

Fadel, E. ;

Mabille, L. ;

Duchemann, B. ;

Barlesi, F. ;

Soria, J-C. ;

Caramella, C. ;

Mercier, O. .

ANNALS OF ONCOLOGY, 2020, 31 :S794-S795

[10] Mediastinal lymph node clearance after docetaxel-cisplatin Neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer:: A multicenter phase II trial [J].

Betticher, DC ;

Schmitz, SFH ;

Tötsch, M ;

Hansen, E ;

Joss, C ;

von Briel, C ;

Schmid, RA ;

Pless, M ;

Habicht, J ;

Roth, AD ;

Spiliopoulos, A ;

Stahel, R ;

Weder, W ;

Stupp, R ;

Egli, F ;

Furrer, M ;

Honegger, H ;

Wernli, M ;

Cerny, T ;

Ris, HB .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (09) :1752-1759

← 1 2 3 4 5 6 7 8 9 10 →